Authors: Zaks-Zilberman, M Zaks, TZ Vogel, SN

Citation: M. Zaks-zilberman et al., Induction of proinflammatory and chemokine genes by lipopolysaccharide andpaclitaxel (Taxol (TM)) in murine and human breast cancer cell lines, CYTOKINE, 15(3), 2001, pp. 156-165

Authors: Karas, M Zaks, TZ Yakar, S Dudley, ME LeRoith, D

Citation: M. Karas et al., TCR stimulation protects CD8(+) T cells from CD95 mediated apoptosis, HUMAN IMMUN, 62(1), 2001, pp. 32-38

Authors: Ying, H Zaks, TZ Wang, RF Irvine, KR Kammula, US Marincola, FM Leitner, WW Restifo, NP

Citation: H. Ying et al., Cancer therapy using a self-replicating RNA vaccine, NAT MED, 5(7), 1999, pp. 823-827

Authors: Karas, M Zaks, TZ Liu, JL LeRoithe, D

Citation: M. Karas et al., T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle, MOL BIOL CE, 10(12), 1999, pp. 4441-4450

Authors: Zaks, TZ Chappell, DB Rosenberg, SA Restifo, NP

Citation: Tz. Zaks et al., Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: Selective rescue by caspase inhibition, J IMMUNOL, 162(6), 1999, pp. 3273-3279

Authors: Chappell, DB Zaks, TZ Rosenberg, SA Restifo, NP

Citation: Db. Chappell et al., Human melanoma cells do not express Fas (Apo-1/CD95) ligand, CANCER RES, 59(1), 1999, pp. 59-62